ARX 1.63% 60.5¢ aroa biosurgery limited

News: ARX Aroa Biosurgery Posts FY22 Product Sales Guidance Of $30M-33M, page-7

  1. 244 Posts.
    lightbulb Created with Sketch. 35
    Hi there Maxkieh,
    What timeframe was this target price?
    Although I love ARX and its management, the company is not well supported/ known by the ASX investors. Perhaps because it is a NZ company it doesn't attract the same fan base that PNV does.
    At $11.00 per share, this would equate to a valuation of over $3.00b for ARX. This is unlikely in the next couple of years. I would love to be proved wrong though. Even PNV currently only has a market cap of $1.86b on similar sales revenue.
    PNV forward sales revenue growth and gross margins are superior to ARX.
    Bell Potter offer a more realistic price target of around $2.10 for ARX.
 
watchlist Created with Sketch. Add ARX (ASX) to my watchlist
(20min delay)
Last
60.5¢
Change
-0.010(1.63%)
Mkt cap ! $208.2M
Open High Low Value Volume
62.0¢ 62.0¢ 58.0¢ $105.9K 173.5K

Buyers (Bids)

No. Vol. Price($)
3 35180 59.0¢
 

Sellers (Offers)

Price($) Vol. No.
60.5¢ 25870 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
ARX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.